Literature DB >> 10683816

The effect of docosahexaenoic acid on plasma catecholamine concentrations and glucose tolerance during long-lasting psychological stress: a double-blind placebo-controlled study.

S Sawazaki1, T Hamazaki, K Yazawa, M Kobayashi.   

Abstract

We previously found that docosahexaenoic acid (DHA) intake prevented aggression from increasing at times of mental stress. In the present study, we investigated whether DHA intake modified the plasma catecholamines and cortisol of medical students during a 9-wk period of final exams. We also investigated the effects of DHA intake on a 75 g oral glucose tolerance test (oGTT). Fourteen medical students participated in the present study. They were randomly allocated to either control or DHA group in a double-blind manner. Subjects in the control group (4 males and 3 females) took 10 control capsules/d, each capsule containing 280 mg of mixed plant oil, and those in the DHA group (4 males and 3 females) took 10 DHA capsules/d containing 1.5 g DHA for 9 wk, during which subjects underwent more than 20 stressful final exams. At the start and end of the study, plasma catecholamines (epinephrine, norepinephrine (NE) and dopamine) and cortisol were measured; a 75 g oGTT was also performed. There were no intra- or intergroup differences in plasma glucose concentrations. However, NE concentrations were significantly reduced after DHA administration (-31%, p < 0.03). The other catecholamines and cortisol did not change significantly. The plasma ratio of epinephrine to NE increased in every DHA subject (+78%, p < 0.02), and intergroup differences were significant (p < 0.03). We conclude that these effects of DHA may be applied to people under long-lasting psychological stress to prevent stress-related diseases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10683816     DOI: 10.3177/jnsv.45.655

Source DB:  PubMed          Journal:  J Nutr Sci Vitaminol (Tokyo)        ISSN: 0301-4800            Impact factor:   2.000


  9 in total

Review 1.  Omega-3 fatty acids for depression in adults.

Authors:  Katherine M Appleton; Hannah M Sallis; Rachel Perry; Andrew R Ness; Rachel Churchill
Journal:  Cochrane Database Syst Rev       Date:  2015-11-05

2.  Depressive symptoms, omega-6:omega-3 fatty acids, and inflammation in older adults.

Authors:  Janice K Kiecolt-Glaser; Martha A Belury; Kyle Porter; David Q Beversdorf; Stanley Lemeshow; Ronald Glaser
Journal:  Psychosom Med       Date:  2007-03-30       Impact factor: 4.312

Review 3.  Omega-3 fatty acids for depression in adults.

Authors:  Katherine M Appleton; Philip D Voyias; Hannah M Sallis; Sarah Dawson; Andrew R Ness; Rachel Churchill; Rachel Perry
Journal:  Cochrane Database Syst Rev       Date:  2021-11-24

4.  EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors.

Authors:  Laura Stevens; Wen Zhang; Louise Peck; Thomas Kuczek; Nels Grevstad; Anne Mahon; Sydney S Zentall; L Eugene Arnold; John R Burgess
Journal:  Lipids       Date:  2003-10       Impact factor: 1.880

5.  Effects of marine-derived omega-3 fatty acids on systemic hemodynamics at rest and during stress: a dose-response study.

Authors:  Ann C Skulas-Ray; Penny M Kris-Etherton; William S Harris; Sheila G West
Journal:  Ann Behav Med       Date:  2012-12

6.  Are the Adaptogenic Effects of Omega 3 Fatty Acids Mediated via Inhibition of Proinflammatory Cytokines?

Authors:  Joanne Bradbury; Lyndon Brooks; Stephen P Myers
Journal:  Evid Based Complement Alternat Med       Date:  2011-10-10       Impact factor: 2.629

Review 7.  Docosahexaenoic acid (DHA): an ancient nutrient for the modern human brain.

Authors:  Joanne Bradbury
Journal:  Nutrients       Date:  2011-05-10       Impact factor: 5.717

8.  An adaptogenic role for omega-3 fatty acids in stress; a randomised placebo controlled double blind intervention study (pilot) [ISRCTN22569553].

Authors:  Joanne Bradbury; Stephen P Myers; Chris Oliver
Journal:  Nutr J       Date:  2004-11-28       Impact factor: 3.271

9.  Tachikawa project for prevention of posttraumatic stress disorder with polyunsaturated fatty acid (TPOP): study protocol for a randomized controlled trial.

Authors:  Yutaka Matsuoka; Daisuke Nishi; Naohiro Yonemoto; Kei Hamazaki; Kenta Matsumura; Hiroko Noguchi; Kenji Hashimoto; Tomohito Hamazaki
Journal:  BMC Psychiatry       Date:  2013-01-05       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.